Search Results 361-370 of 11730 for Drug-resistant TB
Post Approval Study For Treatment Of Drug-resistant Adult Primary FSGS Using The LIPOSORBER® LA-15 System. Jacksonville, Fla., Rochester, Minn., Scottsdale ...
Binimetinib belongs to the group of medicines, called antineoplastics (cancer medicines). This medicine is available only with your doctor's prescription. This ...
Zelalem Temesgen, M.D., studies infectious disease epidemiology, treatment and prevention, primarily focusing on HIV and tuberculosis. His research interests ...
... of life. Immunotherapy for treatment-resistant nonmuscle-invasive bladder cancer. Clinical trials have been instrumental in advancing immunotherapy for ...
Drug Interactions. Although certain medicines ... Tuberculosis, active—Use is not recommended in patients with these conditions. ... Also, the number of doses you ...
035 Endovascular Catheter for the administration of pharmaco-mechanical catheter directed therapy using pulse sprays of r-tPA into the pulmonary arteries for ...
Learn more about the causes, symptoms, treatment and risks of this life-threatening, rare skin disorder, also called toxic epidermal necrolysis.
This medicine is also used to treat malignant effusions (accumulation of fluid in the body cavity) caused by cancer. Thiotepa belongs to the group of medicines ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.